当前位置: X-MOL 学术Hum. Genome Var. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Exome-first approach identified a novel gloss deletion associated with Lowe syndrome.
Human Genome Variation Pub Date : 2016-11-10 , DOI: 10.1038/hgv.2016.37
Miki Watanabe 1 , Ryuji Nakagawa 2 , Tomohiro Kohmoto 1 , Takuya Naruto 1 , Ken-Ichi Suga 2 , Aya Goji 2 , Hideaki Horikawa 3 , Kiyoshi Masuda 1 , Shoji Kagami 2 , Issei Imoto 3
Affiliation  

Lowe syndrome (LS) is an X-linked disorder affecting the eyes, nervous system and kidneys, typically caused by missense or nonsense/frameshift OCRL mutations. We report a 6-month-old male clinically suspected to have LS, but without the Fanconi-type renal dysfunction. Using a targeted-exome sequencing-first approach, LS was diagnosed by the identification of a deletion involving 1.7 Mb at Xq25-q26.1, encompassing the entire OCRL gene and neighboring loci.

中文翻译:

外显子优先方法发现了一种与 Lowe 综合征相关的新型光泽缺失。

Lowe 综合征 (LS) 是一种 X 连锁疾病,影响眼睛、神经系统和肾脏,通常由错义或无义/移码 OCRL 突变引起。我们报告了一名 6 个月大的男性,临床怀疑患有 LS,但没有范可尼型肾功能障碍。使用靶向外显子组测序优先方法,通过鉴定 Xq25-q26.1 处 1.7 Mb 的缺失(涵盖整个 OCRL 基因和邻近基因座)来诊断 LS。
更新日期:2019-11-01
down
wechat
bug